Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience
<b>Background:</b> Next-generation sequencing (NGS), particularly whole-exome sequencing (WES), has become a powerful diagnostic tool for rare genetic conditions. However, its success rate varies based on the underlying genetic etiology and the population studied. <b>Methods</b&...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Medical Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3271/13/2/75 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839653345320501248 |
|---|---|
| author | Milena Stoyanova Dinnar Yahya Mari Hachmeriyan Mariya Levkova |
| author_facet | Milena Stoyanova Dinnar Yahya Mari Hachmeriyan Mariya Levkova |
| author_sort | Milena Stoyanova |
| collection | DOAJ |
| description | <b>Background:</b> Next-generation sequencing (NGS), particularly whole-exome sequencing (WES), has become a powerful diagnostic tool for rare genetic conditions. However, its success rate varies based on the underlying genetic etiology and the population studied. <b>Methods</b>: This retrospective study evaluated the diagnostic yield of NGS in a cohort of 137 pediatric patients with suspected rare genetic disorders in Bulgaria, a setting where such testing is not reimbursed and must be self-funded. The patients underwent either WES or targeted gene panel testing based on clinical presentation, family history, and genetic evaluation. <b>Results</b>: The overall diagnostic yield was 45.99%, with WES achieving 51.25% and targeted testing achieving 38.60%. The highest yield was observed in patients presenting with both dysmorphic features and neurodevelopmental delays (62.5%), while the lowest was observed among those with isolated neurodevelopmental issues (10%). A significant portion of the identified variants (35.9%) were novel. Eight patients were diagnosed with copy number variants (CNVs) detected only through WES. <b>Conclusions</b>: Our findings illustrate the value of WES as a first-line test and highlight the impact of deep phenotyping on diagnostic success. This study also emphasizes the need for a population-specific reference genome and equal access to genomic diagnostics in all European countries. |
| format | Article |
| id | doaj-art-9c5332f03e914b6b88f164983d1bfc6c |
| institution | Matheson Library |
| issn | 2076-3271 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medical Sciences |
| spelling | doaj-art-9c5332f03e914b6b88f164983d1bfc6c2025-06-25T14:10:10ZengMDPI AGMedical Sciences2076-32712025-06-011327510.3390/medsci13020075Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center ExperienceMilena Stoyanova0Dinnar Yahya1Mari Hachmeriyan2Mariya Levkova3Department of Medical Genetics, Medical University Varna, Marin Drinov Str 55, 9000 Varna, BulgariaDepartment of Medical Genetics, Medical University Varna, Marin Drinov Str 55, 9000 Varna, BulgariaDepartment of Medical Genetics, Medical University Varna, Marin Drinov Str 55, 9000 Varna, BulgariaDepartment of Medical Genetics, Medical University Varna, Marin Drinov Str 55, 9000 Varna, Bulgaria<b>Background:</b> Next-generation sequencing (NGS), particularly whole-exome sequencing (WES), has become a powerful diagnostic tool for rare genetic conditions. However, its success rate varies based on the underlying genetic etiology and the population studied. <b>Methods</b>: This retrospective study evaluated the diagnostic yield of NGS in a cohort of 137 pediatric patients with suspected rare genetic disorders in Bulgaria, a setting where such testing is not reimbursed and must be self-funded. The patients underwent either WES or targeted gene panel testing based on clinical presentation, family history, and genetic evaluation. <b>Results</b>: The overall diagnostic yield was 45.99%, with WES achieving 51.25% and targeted testing achieving 38.60%. The highest yield was observed in patients presenting with both dysmorphic features and neurodevelopmental delays (62.5%), while the lowest was observed among those with isolated neurodevelopmental issues (10%). A significant portion of the identified variants (35.9%) were novel. Eight patients were diagnosed with copy number variants (CNVs) detected only through WES. <b>Conclusions</b>: Our findings illustrate the value of WES as a first-line test and highlight the impact of deep phenotyping on diagnostic success. This study also emphasizes the need for a population-specific reference genome and equal access to genomic diagnostics in all European countries.https://www.mdpi.com/2076-3271/13/2/75next-generation sequencingrare diseasediagnostic yieldsuccess rategenetic counseling |
| spellingShingle | Milena Stoyanova Dinnar Yahya Mari Hachmeriyan Mariya Levkova Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience Medical Sciences next-generation sequencing rare disease diagnostic yield success rate genetic counseling |
| title | Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience |
| title_full | Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience |
| title_fullStr | Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience |
| title_full_unstemmed | Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience |
| title_short | Diagnostic Yield of Next-Generation Sequencing for Rare Pediatric Genetic Disorders: A Single-Center Experience |
| title_sort | diagnostic yield of next generation sequencing for rare pediatric genetic disorders a single center experience |
| topic | next-generation sequencing rare disease diagnostic yield success rate genetic counseling |
| url | https://www.mdpi.com/2076-3271/13/2/75 |
| work_keys_str_mv | AT milenastoyanova diagnosticyieldofnextgenerationsequencingforrarepediatricgeneticdisordersasinglecenterexperience AT dinnaryahya diagnosticyieldofnextgenerationsequencingforrarepediatricgeneticdisordersasinglecenterexperience AT marihachmeriyan diagnosticyieldofnextgenerationsequencingforrarepediatricgeneticdisordersasinglecenterexperience AT mariyalevkova diagnosticyieldofnextgenerationsequencingforrarepediatricgeneticdisordersasinglecenterexperience |